Secondary progressive multiple sclerosis – Life with Disease

Go back

Secondary progressive multiple sclerosis represents a stage in the journey of multiple sclerosis where the disease shifts from periods of relapses and recovery to a pattern of steady worsening over time, bringing new challenges and adaptations to daily life.

Understanding Prognosis and Life Expectancy

Coming to terms with a diagnosis of secondary progressive multiple sclerosis can feel overwhelming, and it’s natural to wonder about what lies ahead. The outlook for SPMS varies considerably from person to person, making it difficult to predict exactly how the condition will progress for any individual. What we do know is that symptoms tend to worsen gradually over time, but the pace at which this happens differs greatly between people[1].

Research shows that the transition from relapsing-remitting MS to secondary progressive MS typically occurs between 10 and 25 years after the initial diagnosis. Most people with relapsing-remitting MS will eventually develop SPMS, with studies indicating that around 25% of people progress within 10 years, 50% within 20 years, and more than 75% within 30 years. The average age when this transition happens is around 40 years[11]. However, these are averages, and modern disease-modifying treatments may be changing these timelines for the better.

It’s important to understand that having SPMS does not mean you will immediately become severely disabled. About two-thirds of people with SPMS are able to walk and do not require a wheelchair. While some people may benefit from mobility aids like canes or walkers, and others might use a scooter or motorized chair for more strenuous activities, many maintain significant independence[18]. The rate of progression can be slow and gradual over many years, though for some individuals it may move more rapidly.

Several factors appear to influence how quickly SPMS progresses. Men may experience faster progression than women. People who had more frequent and severe relapses during the relapsing-remitting phase, or those who had MS symptoms that started later in life, may be at higher risk for more rapid progression[1]. Additionally, those who have large numbers of lesions in their brain and spinal cord at the time of diagnosis may face greater challenges[2].

⚠️ Important
When you hear the word “progression,” it can be frightening and may bring up images of severe disability. However, this is not always the case. Multiple sclerosis is heterogeneous, meaning no two people with SPMS will be exactly the same. One person may have significant impairment while another may have far less, or may have different types of symptoms altogether.

Natural Progression of the Disease

Understanding how secondary progressive multiple sclerosis develops naturally helps make sense of the changes happening in your body. The disease follows a pattern that builds upon damage that began during the earlier relapsing-remitting phase. During relapsing-remitting MS, your immune system mistakenly attacks myelin, which is the protective covering around nerve fibers in your brain and spinal cord. Think of myelin like the insulation around an electrical wire. When it’s damaged, nerve signals can’t travel as efficiently[1].

In the relapsing-remitting stage, most damage comes from sudden inflammatory attacks or relapses. Between these attacks, your body has some ability to repair the damage, which is why symptoms often improve during remission periods. However, over time, this damage accumulates. Eventually, the repeated attacks begin to harm not just the myelin coating but the actual nerve fibers underneath. When you transition to SPMS, your nerves continue to deteriorate gradually, even without dramatic flare-up attacks. This steady nerve damage is what makes symptoms progressively more intense[1].

The transition from relapsing-remitting MS to secondary progressive MS happens gradually, which is why doctors may not be able to pinpoint exactly when it occurs. Before a diagnosis of SPMS can be considered, a person needs to experience about six months of observed worsening of neurological symptoms without experiencing a relapse. If worsening symptoms are simply leftovers from the last relapse, with permanent but stable damage, the disease is still considered relapsing-remitting. But if the disease continues to worsen even though inflammatory relapses are no longer occurring frequently, the transition to SPMS has taken place[15].

There are actually two subtypes of secondary progressive MS. In inactive or nonrelapsing SPMS, relapses stop entirely and symptoms simply worsen slowly and steadily over time. In active or relapsing SPMS, you may still experience some flare-ups even as your overall condition gradually declines[1]. Some people with SPMS continue to show new inflammation in their brain and spinal cord on imaging tests, though this occurs less frequently than during the relapsing-remitting phase.

Without treatment, the natural progression of SPMS involves increasing disability over time. The central nervous system, which includes your brain and spinal cord, serves as your body’s command center. The spinal cord governs movement and other functions, while the brain manages higher-level functions and interprets messages. As MS interrupts these functions, symptoms such as generalized fatigue, slowed thinking, changes in vision, coordination problems, weakness, walking difficulties, and loss of bladder and bowel control become more pronounced and persistent[15].

Possible Complications

As secondary progressive multiple sclerosis advances, various complications can develop that affect different parts of your body and daily functioning. These complications arise from the ongoing damage to nerve pathways in your brain and spinal cord, and they can significantly impact your quality of life if not properly managed.

Walking difficulties and mobility problems are among the most common complications. You may notice increasing trouble with balance, coordination, and the ability to walk distances that were once manageable. Muscle stiffness, known as spasticity, can develop in your legs and other parts of your body, making movement more difficult and sometimes painful. Muscle spasms may occur unpredictably, causing discomfort and interfering with daily activities[1]. These mobility challenges increase the risk of falls, which can lead to fractures and other injuries.

Bladder and bowel problems become more frequent as the disease progresses. You might experience an urgent need to urinate, difficulty emptying your bladder completely, or episodes of incontinence. Similarly, bowel function may be affected, leading to constipation or, less commonly, loss of bowel control. These complications can be particularly distressing and may cause people to avoid social situations or travel[1].

Cognitive changes represent another significant complication. You may find yourself struggling with memory, having difficulty concentrating, experiencing slowed information processing, or dealing with what’s commonly called “brain fog.” These thinking and memory problems can affect your ability to work, manage household responsibilities, and engage in complex conversations. While these cognitive symptoms were present to some degree in earlier stages of MS, they often become more pronounced in SPMS[4].

Vision problems can worsen over time, including double vision, blurred vision, or partial loss of vision. Strange sensations such as numbness, tingling, or the “MS hug”—a feeling of tightness around the chest or torso—may become more frequent or persistent. Some people experience increased pain as the disease progresses, which can take various forms including nerve pain, muscle pain, or headaches[4].

Fatigue in SPMS can be overwhelming and is often described as different from ordinary tiredness. This type of fatigue doesn’t necessarily improve with rest and can make even simple tasks feel exhausting. It’s one of the most common and disabling symptoms, affecting your ability to work, socialize, and participate in activities you once enjoyed[15].

Emotional and mental health complications are also common. Depression and anxiety occur at higher rates among people with SPMS, which is understandable given the challenges of living with a progressive condition. The stress of coping with increasing symptoms, the loss of abilities, and uncertainty about the future can take a significant toll on emotional wellbeing[18].

Impact on Daily Life

Secondary progressive multiple sclerosis affects virtually every aspect of daily living, requiring significant adjustments to routines, environments, and expectations. The progressive nature of the symptoms means that activities you once performed easily may gradually become more challenging, necessitating new strategies and accommodations.

Physical activities are often the most visibly affected area of daily life. Simple tasks like getting dressed, preparing meals, or cleaning the house can become exhausting and time-consuming as fatigue increases and mobility decreases. You might find that you can no longer stand for long periods, which affects cooking, shopping, and other standing activities. Walking distances that were once manageable may now require rest breaks or the use of mobility aids. Stairs can become particularly challenging, potentially affecting your ability to access all areas of your home[13].

Your work life may be significantly impacted by SPMS. Cognitive changes like difficulty concentrating, memory problems, and slowed thinking can make complex tasks more challenging. Physical symptoms such as fatigue may mean you can’t maintain a full-time schedule or need more frequent breaks. Some people find they need to request workplace accommodations, reduce their hours, change to less demanding positions, or eventually stop working altogether. This can affect not only your income but also your sense of identity and purpose[15].

Social and leisure activities often require modification. Hobbies that involve fine motor skills may become difficult if you experience tremors or coordination problems. Social gatherings that once energized you might now feel exhausting due to fatigue. Bladder urgency or concerns about falling can make you hesitant to venture far from home or attend events in unfamiliar places. Some people begin to withdraw from social activities, which can lead to isolation and worsen depression[18].

Family dynamics and relationships undergo changes as well. Roles within your household may need to shift. If you were previously the primary cook, cleaner, or caregiver for children or aging parents, family members may need to take on more of these responsibilities. This role reversal can create feelings of guilt, frustration, and loss of independence on your part, and may cause stress and resentment in family members who take on additional duties. Intimate relationships may be affected by physical symptoms, fatigue, and emotional changes[15].

Your home environment may require modifications to maintain safety and independence. Clearing walkways of clutter to prevent tripping, installing grab bars in bathrooms, adjusting furniture height to make sitting and standing easier, and possibly making more significant modifications like widening doorways or installing ramps become important considerations. These changes, while practical, serve as constant reminders of your disease progression[13].

Managing daily self-care can become more complex. You might need to allow extra time in the morning for getting ready, as dressing, bathing, and grooming take longer. Adapting your schedule to work with your energy levels becomes essential—many people find they have more energy at certain times of day and plan important activities accordingly. Getting enough rest becomes crucial, yet sleep problems are common in SPMS, creating a challenging cycle[14].

⚠️ Important
Practicing overall healthy lifestyle habits remains essential with SPMS. Eating a well-balanced diet, staying as active as possible within your limitations, maintaining a moderate weight, and getting enough rest can help improve your energy levels, strength, mood, and cognitive function. It’s also critical to avoid tobacco smoke to limit symptoms and promote overall health.

Transportation and mobility outside the home present their own challenges. Driving may become difficult or unsafe due to vision problems, slowed reactions, or cognitive changes. This loss of driving independence can be particularly difficult for those who live in areas without good public transportation. Planning outings requires consideration of accessible parking, bathroom locations, and whether you’ll be able to manage the physical demands of the activity.

Financial concerns often arise as medical expenses increase and income may decrease. The cost of medications, medical equipment, home modifications, and potentially reduced work hours or disability retirement can create significant financial stress. Navigating insurance coverage, disability benefits, and financial assistance programs adds another layer of complexity to daily life.

Support for Family Members and Caregivers

When someone in your family has secondary progressive multiple sclerosis, it affects everyone. Family members and caregivers play a crucial role in supporting their loved one, but they also need support, information, and strategies to navigate this challenging journey together. Understanding what clinical trials offer and how to help someone participate can be an important part of managing SPMS.

Clinical trials represent an opportunity to access new treatments that aren’t yet widely available and to contribute to advancing medical knowledge about SPMS. For families, understanding clinical trials begins with recognizing that they are carefully designed research studies that test whether new treatments are safe and effective. These trials have strict guidelines to protect participants and are conducted only after extensive laboratory and animal testing has shown promise[4].

If your family member is considering a clinical trial, you can help by researching available trials together. Many trials specifically recruit people with secondary progressive MS because this stage of the disease has historically had fewer treatment options. New therapies being tested aim to slow progression, manage symptoms, or protect nerve cells from further damage. Your role might include helping to identify trials that match your loved one’s specific situation, stage of disease, and other medical conditions.

Preparing for potential trial participation involves practical support. You might help gather medical records, coordinate with current healthcare providers, and ensure your family member gets to screening appointments. Clinical trials often require frequent visits to medical centers, sometimes located far from home. As a family member, you might provide transportation, accompany your loved one to appointments to help remember information discussed, and take notes about instructions or observations to share with the research team.

Understanding what participation entails helps families make informed decisions. Clinical trials may require more frequent monitoring than standard care, including additional blood tests, imaging studies like MRIs, and detailed symptom assessments. Some trials test medications, while others might evaluate rehabilitation approaches, medical devices, or lifestyle interventions. Your loved one might receive the experimental treatment, or they might receive a placebo or standard treatment as part of the comparison group. This uncertainty can be difficult, but it’s a necessary part of determining whether new treatments actually work.

Family support during a trial extends beyond logistics. Emotional encouragement becomes important, especially if your loved one doesn’t notice immediate benefits or experiences side effects. Helping track symptoms, medication timing, and any changes can provide valuable information to the research team. You might also help your family member decide if they need to withdraw from a trial if side effects become too burdensome or circumstances change.

Beyond clinical trials, families can support their loved one with SPMS in numerous ways. Learning about the disease helps you understand what they’re experiencing. Many people with SPMS report that others don’t truly comprehend how disabling fatigue can be, or how cognitive changes affect daily functioning. Educating yourself helps you respond with empathy rather than frustration when plans need to change or tasks take longer than expected.

Practical assistance makes a significant difference. This might include help with household tasks, meal preparation, shopping, transportation, and personal care as needed. However, it’s important to balance providing help with allowing your loved one to maintain as much independence as possible. Over-helping can rob someone of their sense of competence and autonomy, while under-helping can leave them struggling unnecessarily. Open communication about what help is wanted and needed works best.

Advocating for your family member in medical settings can be valuable. You might help communicate with doctors, ask questions your loved one might forget, and ensure concerns are addressed. Many people find it helpful to have a family member present at important appointments to serve as a second set of ears, as medical information can be overwhelming and difficult to remember.

Families should also be aware of the emotional toll of SPMS. Depression and anxiety are common, and your loved one may need encouragement to seek mental health support. Creating an environment where feelings can be discussed openly, without judgment, helps everyone cope better. Family counseling can provide a safe space to address the changing dynamics, resentments, fears, and grief that often accompany progressive illness.

Taking care of yourself as a caregiver is not selfish—it’s essential. Caregiver burnout is real and can lead to physical and emotional health problems. Seeking support through caregiver support groups, taking regular breaks, maintaining your own social connections and hobbies, and possibly arranging respite care helps you sustain your caregiving role over the long term. Many organizations offer resources specifically for MS caregivers, including educational programs, support groups, and financial assistance information.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Siponimod (Mayzent) – FDA-approved disease-modifying drug specifically for treating secondary progressive MS, works by reducing immune system attacks on nerve cells
  • Cladribine (Leustatin, Mavenclad) – FDA-approved disease-modifying drug specifically for SPMS, works by stopping the immune system attack against myelin
  • Mitoxantrone (Novantrone) – Chemotherapy drug that can be used for SPMS by stopping immune system attacks on myelin, though not used frequently due to potential serious side effects including heart problems
  • Ublituximab-xiiy (Briumvi) – FDA-approved drug specifically for treating secondary progressive MS
  • Alemtuzumab (Lemtrada) – Disease-modifying drug that can be used for active SPMS to help prevent relapses
  • Diroximel fumarate (Vumerity) – Disease-modifying therapy used for active SPMS
  • Dimethyl fumarate (Tecfidera) – Disease-modifying drug for treating active forms of SPMS
  • Fingolimod (Gilenya) – Disease-modifying therapy used for active SPMS
  • Glatiramer acetate (Copaxone) – Disease-modifying drug that can be used for active SPMS
  • Interferon beta-1b (Avonex, Betaseron, Extavia, Plegridy, Rebif) – Disease-modifying therapy used for active SPMS to help prevent relapses
  • Monomethyl fumarate (Bafiertam) – Disease-modifying drug for active SPMS
  • Natalizumab (Tysabri) – Disease-modifying therapy used for active forms of SPMS
  • Ocrelizumab (Ocrevus) – Disease-modifying drug that can be used for active SPMS
  • Ofatumumab (Kesimpta) – Disease-modifying therapy for active SPMS
  • Ozanimod (Zeposia) – Disease-modifying drug used for active SPMS
  • Ponesimod (Ponvory) – Disease-modifying therapy for active SPMS
  • Teriflunomide (Aubagio) – Disease-modifying drug that can be used for active SPMS
  • Corticosteroids – Used for short-term treatment of relapses to bring down inflammation and make relapses shorter and less severe

Ongoing Clinical Trials on Secondary progressive multiple sclerosis

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1
    France Germany Italy Spain
  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    1 1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

    Not yet recruiting

    1 1 1
    Denmark The Netherlands
  • Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Denmark
  • Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

    Not recruiting

    1 1
    Belgium
  • Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

    Not recruiting

    1 1 1 1
    France

References

https://my.clevelandclinic.org/health/diseases/secondary-progressive-ms-spms

https://www.cedars-sinai.org/health-library/diseases-and-conditions/s/secondary-progressive-multiple-sclerosis.html

https://mstrust.org.uk/a-z/secondary-progressive-ms

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/spms

https://pubmed.ncbi.nlm.nih.gov/27401521/

https://www.webmd.com/multiple-sclerosis/secondary-progressive-ms

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

https://www.webmd.com/multiple-sclerosis/spms-treatments

https://my.clevelandclinic.org/health/diseases/secondary-progressive-ms-spms

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://pmc.ncbi.nlm.nih.gov/articles/PMC6472227/

https://mstrust.org.uk/a-z/secondary-progressive-ms

https://www.everydayhealth.com/neurological-disorders/tips-for-creating-a-safe-home-for-secondary-progressive-ms/

https://www.healthline.com/health/secondary-progressive-ms/lifestyle-modifications

https://www.healthwellfoundation.org/realworldhealthcare/navigating-secondary-progressive-ms/

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/spms

https://mstrust.org.uk/a-z/secondary-progressive-ms

https://www.webmd.com/multiple-sclerosis/emotional-impact-spms

https://ameripharmaspecialty.com/multiple-sclerosis/10-tips-for-living-with-multiple-sclerosis/

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How do doctors know when I’ve transitioned from relapsing-remitting MS to secondary progressive MS?

The diagnosis of SPMS is usually made when your symptoms have steadily worsened for at least six months without experiencing a relapse. Your doctor will review your medical history, track your symptoms over time, and may use tests like MRI scans to look at nerve damage in your brain and spinal cord. The transition happens gradually, so doctors may not be able to pinpoint exactly when it occurred.

Can I still have relapses if I have secondary progressive MS?

Yes, some people with SPMS continue to experience occasional relapses. This is called active or relapsing secondary progressive MS. However, relapses occur less frequently than during the relapsing-remitting phase, and the main feature of SPMS is that symptoms gradually worsen over time regardless of whether relapses occur.

Will I definitely need a wheelchair if I have secondary progressive MS?

No, not everyone with SPMS needs a wheelchair. About two-thirds of people with SPMS are able to walk and don’t require a wheelchair. While you might benefit from mobility aids like a cane or walker at some point, and some people use a scooter for more strenuous activities, many people maintain the ability to walk with support.

Are the medications I took for relapsing-remitting MS still effective for SPMS?

It depends on whether you have active SPMS (still experiencing some relapses) or non-active SPMS (no relapses). If you have active SPMS, your doctor may recommend continuing disease-modifying drugs that help prevent relapses. Several medications are specifically FDA-approved for SPMS, including siponimod, cladribine, and ublituximab-xiiy. Your doctor will help determine the best treatment approach for your specific situation.

What lifestyle changes can help me manage secondary progressive MS?

Several lifestyle modifications can help manage SPMS symptoms. These include eating a well-balanced diet, staying as physically active as possible within your limitations, getting adequate rest, avoiding tobacco smoke, and maintaining a moderate weight. Exercise has been shown to help reduce fatigue, improve strength and mobility, boost mood, and enhance overall health. You might also benefit from home modifications like clearing walkways, installing grab bars, and adjusting furniture heights to maintain safety and independence.

🎯 Key takeaways

  • Secondary progressive MS develops after relapsing-remitting MS, typically 10-25 years after initial diagnosis, with symptoms steadily worsening rather than coming and going in relapses.
  • Modern disease-modifying treatments appear to be delaying the transition to SPMS and slowing progression once it develops.
  • SPMS affects each person differently—there’s no single pathway, and about two-thirds of people maintain the ability to walk without a wheelchair.
  • Several FDA-approved medications specifically target secondary progressive MS, including siponimod, cladribine, and ublituximab-xiiy.
  • Lifestyle modifications including exercise, balanced nutrition, adequate rest, and avoiding tobacco can significantly help manage symptoms and maintain quality of life.
  • Home modifications and mobility aids aren’t signs of giving up—they’re practical tools that help you maintain independence and safety.
  • Clinical trials offer opportunities to access new treatments and contribute to advancing knowledge about SPMS management.
  • Family support and caregiver wellbeing are essential components of successfully navigating life with SPMS, requiring open communication and shared adjustment.